Associate Professor John Furler
Department of General Practice
The University of Melbourne
MAIN CONFERENCE SESSION
A Roundtable Discussion On Conducting Complex Intervention Trials In Primary Care Settings
Date: 22 September 2017, Friday
Time: 10.45am – 12.45pm
Synopsis: Conducting complex intervention trials in primary care requires a multidisciplinary team consisting of health professionals, epidemiologists, biostatisticians, health economists and social scientists. This workshop will bring together a team of Family Medicine/General Practice researchers from Hong Kong, Australia, Malaysia and Singapore sharing their experiences in conducting complex intervention trials in primary care settings. It will be delivered in the format of a roundtable whereby 5-6 speakers will give a 5-minute brief on their experiences in conducting such trials in general practice/family medicine and other primary care settings. Challenges and barriers including funding support and what to do with a negative trial will also be shared. It will be an interactive session with active participation from attendees who will be called upon to comment and ask questions of the speakers. It is envisaged that the outcome of this workshop will be the formation of an Asia-Pacific research leadership initiative to build primary care research capacity in the region.
Associate Professor John Furler is recognised nationally and internationally as a leader in Primary Care type 2 diabetes and health equity research. He has had sustained Australian NHMRC research support since 2003, most recently being awarded a National Health and Medical Research Council Translating Research Into Practice (NHMRC TRIP) Fellowship (2017-18). He was an early participant in the Brisbane International Initiative (BII) to build international leaders in primary care research (2007-2010). His research involves collaboration with researchers in UK and increasingly with researchers in Hong Kong, China, Singapore and India. He is Associate Editor of the International Journal for Equity in Health and a member of the Editorial Board of the Australian Journal of Primary Health and of Primary Care Diabetes. His total career grant funding is $12.7 million in total funding for grants as an investigator, $3.2 million as Chief Investigator A (CIA).
He has been a Chief Investigator on a range of NHMRC funded large intervention studies of complex interventions and was Principal Investigator on a series of linked studies designed to facilitate General Practitioner-Practice Nurse (GP-PN) based initiation of insulin. He is currently leading a randomised controlled trial (RCT) to test a novel digital technology to help general practitioners (GPs) and patients with type 2 diabetes develop highly personalised approaches to intensifying treatment to achieve glycaemic targets.
He has been a practicing GP at North Richmond Community Health Centre in Melbourne since 1994, having worked as GP in both inner city London and remote indigenous communities in Australia.